Weill David 4
4 · TransMedics Group, Inc. · Filed Nov 14, 2022
Insider Transaction Report
Form 4
Weill David
Director
Transactions
- Sale
Common Stock
2022-11-10$56.00/sh−21,645$1,212,120→ 13,500 total - Exercise/Conversion
Common Stock
2022-11-10$16.00/sh+21,645$346,320→ 35,145 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-11-10−21,645→ 0 totalExercise: $16.00Exp: 2029-05-01→ Common Stock (21,645 underlying)
Footnotes (1)
- [F1]The option is fully vested.